Expert Interview

This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

A Second View: Discussing the Launch of Zynrelef, following its approval in May 2021 as post-surgical analgesia and it's recent label expansion (December 2021)

Ticker(s): HRTX

Who's the expert?

Institution: Cascade Orthopedics

Military-trained orthopedic surgeon with a broad skillset in treating muscoskeletal disorders.
Per month, does 15-20 total hip and knee replacements.
Currently uses the On-Q pain pump post-operatively for all my total knee replacements. Just using bupivacaine currently, but would certainly be willing to try Zynrelef.

Interview Goal

To discuss the use of Zynrelef for soft tissue or periarticular instillation as post-surgical analgesia in patients undergoing bunionectomy, open inguinal herniorrhaphy and total knee arthroplasty and it's recent label expansion (December 2021) for the post-surgical setting following foot and ankle, small-to-medium open abdominal, and lower extremity total joint arthroplasty surgical procedures

Do you want answers to these questions?

Yes! Sign me up for FREE
so I can learn more Yes.
LOGIN!

Click Here to Access
This Project

Slingshot Insights Explained

JOIN FOR FREE TODAY

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

Click Here to Access
This Project

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.